Activities for the Development of Targeted Radionuclide Therapy in Japan View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12-15

AUTHORS

Seigo Kinuya

ABSTRACT

Targeted radionuclide therapy (TRT) is unique because of its efficacy and its theranostic feature in the era of precision medicine. So far, introduction of new TRT has not been going well in Japan due to several reasons including strict regulations, shortage of facilities for TRT, and insufficient reimbursement for TRT in clinic. Japanese community had several strategies to develop TRT in these 10 years, including the establishment of the National Conference for Nuclear Medicine Theranostics in which physicians, scientists, patients, people supporting patients, and industrial people gather. To promote TRT with supports from the government, the preparatory committee for the establishment of Japan Foundation of Medical Isotope Development (JAFMID) was launched. I would like to call TRT “Precision Nuclear Medicine.” When we can add genomic information here, we can put it to new stage of cancer therapy. It is time for us. More... »

PAGES

35-37

References to SciGraph publications

  • 2018-01-15. Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.) in ANNALS OF NUCLEAR MEDICINE
  • 2018-07-13. Prognostic value of 68 Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer in ANNALS OF NUCLEAR MEDICINE
  • 2018-11-27. Introduction of the targeted alpha therapy (with Radium-223) into clinical practice in Japan: learnings and implementation in ANNALS OF NUCLEAR MEDICINE
  • 2017-03-18. Long-term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y/177Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study in ANNALS OF NUCLEAR MEDICINE
  • 2012-03-27. Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy in ANNALS OF NUCLEAR MEDICINE
  • 2018-07-07. Reproducibility of standardized uptake values of same-day randomized 68Ga-PSMA-11 PET/CT and PET/MR scans in recurrent prostate cancer patients in ANNALS OF NUCLEAR MEDICINE
  • 2018-01-18. The influence of elevated hormone levels on physiologic accumulation of 68Ga-DOTATOC in ANNALS OF NUCLEAR MEDICINE
  • 2018-11-07. Phase I/IIa PET imaging study with 89zirconium labeled anti-PSMA minibody for urological malignancies in ANNALS OF NUCLEAR MEDICINE
  • 2018-08-14. Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications in ANNALS OF NUCLEAR MEDICINE
  • 2018-05-23. Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy in ANNALS OF NUCLEAR MEDICINE
  • 2018-08-13. CXCR4-directed theranostics in oncology and inflammation in ANNALS OF NUCLEAR MEDICINE
  • 2017-08-22. Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia in ANNALS OF NUCLEAR MEDICINE
  • 2017-09-12. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer in ANNALS OF NUCLEAR MEDICINE
  • 2015-03-14. Draft guidelines regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors in ANNALS OF NUCLEAR MEDICINE
  • 2018-01-19. Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-09-20. Clinical feasibility of early scanning after administration of 68Ga-DOTATOC in ANNALS OF NUCLEAR MEDICINE
  • 2018-02-21. 68Ga-DOTATATE PET–CT imaging in carotid body paragangliomas in ANNALS OF NUCLEAR MEDICINE
  • 2017-10-24. Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma in ANNALS OF NUCLEAR MEDICINE
  • 2018-07-26. Large cell neuroendocrine carcinoma of the lung with atypical evolution and a remarkable response to lutetium Lu 177 dotatate in ANNALS OF NUCLEAR MEDICINE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s13139-018-0563-4

    DOI

    http://dx.doi.org/10.1007/s13139-018-0563-4

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1110668571

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30828398


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/02", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Physical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0299", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Other Physical Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takaramachi, 920-8641, Kanazawa, Ishikawa, Japan", 
              "id": "http://www.grid.ac/institutes/grid.412002.5", 
              "name": [
                "Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takaramachi, 920-8641, Kanazawa, Ishikawa, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kinuya", 
            "givenName": "Seigo", 
            "id": "sg:person.0620177742.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620177742.17"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s12149-018-1276-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105856637", 
              "https://doi.org/10.1007/s12149-018-1276-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-015-0960-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006620729", 
              "https://doi.org/10.1007/s12149-015-0960-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1233-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100471058", 
              "https://doi.org/10.1007/s12149-018-1233-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1277-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105568984", 
              "https://doi.org/10.1007/s12149-018-1277-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1230-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100399578", 
              "https://doi.org/10.1007/s12149-018-1230-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1291-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1106150181", 
              "https://doi.org/10.1007/s12149-018-1291-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1304-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1107121645", 
              "https://doi.org/10.1007/s12149-018-1304-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-017-1216-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1092351426", 
              "https://doi.org/10.1007/s12149-017-1216-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1264-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1104152081", 
              "https://doi.org/10.1007/s12149-018-1264-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-017-1163-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084034239", 
              "https://doi.org/10.1007/s12149-017-1163-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1290-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1106125946", 
              "https://doi.org/10.1007/s12149-018-1290-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-017-1207-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091594397", 
              "https://doi.org/10.1007/s12149-017-1207-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1242-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1101142948", 
              "https://doi.org/10.1007/s12149-018-1242-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-017-3919-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100478294", 
              "https://doi.org/10.1007/s00259-017-3919-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1317-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1110227037", 
              "https://doi.org/10.1007/s12149-018-1317-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1275-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105345400", 
              "https://doi.org/10.1007/s12149-018-1275-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-017-1201-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091287901", 
              "https://doi.org/10.1007/s12149-017-1201-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1312-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1109759418", 
              "https://doi.org/10.1007/s12149-018-1312-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-012-0590-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038929936", 
              "https://doi.org/10.1007/s12149-012-0590-7"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-12-15", 
        "datePublishedReg": "2018-12-15", 
        "description": "Targeted radionuclide therapy (TRT) is unique because of its efficacy and its theranostic feature in the era of precision medicine. So far, introduction of new TRT has not been going well in Japan due to several reasons including strict regulations, shortage of facilities for TRT, and insufficient reimbursement for TRT in clinic. Japanese community had several strategies to develop TRT in these 10\u00a0years, including the establishment of the National Conference for Nuclear Medicine Theranostics in which physicians, scientists, patients, people supporting patients, and industrial people gather. To promote TRT with supports from the government, the preparatory committee for the establishment of Japan Foundation of Medical Isotope Development (JAFMID) was launched. I would like to call TRT \u201cPrecision Nuclear Medicine.\u201d When we can add genomic information here, we can put it to new stage of cancer therapy. It is time for us.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s13139-018-0563-4", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.5904522", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1016285", 
            "issn": [
              "1869-3474", 
              "1869-3482"
            ], 
            "name": "Nuclear Medicine and Molecular Imaging", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "53"
          }
        ], 
        "keywords": [
          "targeted radionuclide therapy", 
          "radionuclide therapy", 
          "insufficient reimbursement", 
          "therapy", 
          "shortage of facilities", 
          "precision medicine", 
          "cancer therapy", 
          "patients", 
          "Japanese community", 
          "nuclear medicine", 
          "medicine", 
          "Precision Nuclear Medicine", 
          "clinic", 
          "physicians", 
          "efficacy", 
          "reimbursement", 
          "National Conference", 
          "people", 
          "years", 
          "Committee", 
          "development", 
          "activity", 
          "regulation", 
          "Japan", 
          "establishment", 
          "strict regulations", 
          "stage", 
          "support", 
          "theranostic features", 
          "strategies", 
          "genomic information", 
          "reasons", 
          "facilities", 
          "time", 
          "theranostics", 
          "features", 
          "shortage", 
          "conference", 
          "information", 
          "era", 
          "introduction", 
          "community", 
          "industrial people", 
          "foundation", 
          "scientists", 
          "Preparatory Committee", 
          "new stage", 
          "government", 
          "Japan Foundation"
        ], 
        "name": "Activities for the Development of Targeted Radionuclide Therapy in Japan", 
        "pagination": "35-37", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1110668571"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s13139-018-0563-4"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30828398"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s13139-018-0563-4", 
          "https://app.dimensions.ai/details/publication/pub.1110668571"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T21:03", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_761.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s13139-018-0563-4"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0563-4'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0563-4'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0563-4'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0563-4'


     

    This table displays all metadata directly associated to this object as RDF triples.

    188 TRIPLES      21 PREDICATES      93 URIs      66 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s13139-018-0563-4 schema:about anzsrc-for:02
    2 anzsrc-for:0299
    3 schema:author Nc8926295acf741d3a95aff19daed2f94
    4 schema:citation sg:pub.10.1007/s00259-017-3919-6
    5 sg:pub.10.1007/s12149-012-0590-7
    6 sg:pub.10.1007/s12149-015-0960-z
    7 sg:pub.10.1007/s12149-017-1163-6
    8 sg:pub.10.1007/s12149-017-1201-4
    9 sg:pub.10.1007/s12149-017-1207-y
    10 sg:pub.10.1007/s12149-017-1216-x
    11 sg:pub.10.1007/s12149-018-1230-7
    12 sg:pub.10.1007/s12149-018-1233-4
    13 sg:pub.10.1007/s12149-018-1242-3
    14 sg:pub.10.1007/s12149-018-1264-x
    15 sg:pub.10.1007/s12149-018-1275-7
    16 sg:pub.10.1007/s12149-018-1276-6
    17 sg:pub.10.1007/s12149-018-1277-5
    18 sg:pub.10.1007/s12149-018-1290-8
    19 sg:pub.10.1007/s12149-018-1291-7
    20 sg:pub.10.1007/s12149-018-1304-6
    21 sg:pub.10.1007/s12149-018-1312-6
    22 sg:pub.10.1007/s12149-018-1317-1
    23 schema:datePublished 2018-12-15
    24 schema:datePublishedReg 2018-12-15
    25 schema:description Targeted radionuclide therapy (TRT) is unique because of its efficacy and its theranostic feature in the era of precision medicine. So far, introduction of new TRT has not been going well in Japan due to several reasons including strict regulations, shortage of facilities for TRT, and insufficient reimbursement for TRT in clinic. Japanese community had several strategies to develop TRT in these 10 years, including the establishment of the National Conference for Nuclear Medicine Theranostics in which physicians, scientists, patients, people supporting patients, and industrial people gather. To promote TRT with supports from the government, the preparatory committee for the establishment of Japan Foundation of Medical Isotope Development (JAFMID) was launched. I would like to call TRT “Precision Nuclear Medicine.” When we can add genomic information here, we can put it to new stage of cancer therapy. It is time for us.
    26 schema:genre article
    27 schema:isAccessibleForFree true
    28 schema:isPartOf Ndbe85781c8ea48a38461512676e9217a
    29 Nf12f1409d9a04984a95874361d246a55
    30 sg:journal.1016285
    31 schema:keywords Committee
    32 Japan
    33 Japan Foundation
    34 Japanese community
    35 National Conference
    36 Precision Nuclear Medicine
    37 Preparatory Committee
    38 activity
    39 cancer therapy
    40 clinic
    41 community
    42 conference
    43 development
    44 efficacy
    45 era
    46 establishment
    47 facilities
    48 features
    49 foundation
    50 genomic information
    51 government
    52 industrial people
    53 information
    54 insufficient reimbursement
    55 introduction
    56 medicine
    57 new stage
    58 nuclear medicine
    59 patients
    60 people
    61 physicians
    62 precision medicine
    63 radionuclide therapy
    64 reasons
    65 regulation
    66 reimbursement
    67 scientists
    68 shortage
    69 shortage of facilities
    70 stage
    71 strategies
    72 strict regulations
    73 support
    74 targeted radionuclide therapy
    75 theranostic features
    76 theranostics
    77 therapy
    78 time
    79 years
    80 schema:name Activities for the Development of Targeted Radionuclide Therapy in Japan
    81 schema:pagination 35-37
    82 schema:productId N23e47edddf8d40f188c5da9d5055f22a
    83 N3a4f64e4514a4a5881170e3d2ba03e57
    84 N8ba641a7573941f6973ac5ac3195024d
    85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110668571
    86 https://doi.org/10.1007/s13139-018-0563-4
    87 schema:sdDatePublished 2022-11-24T21:03
    88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    89 schema:sdPublisher N625ce9e6d0214a7b884c9e36bbaa46a1
    90 schema:url https://doi.org/10.1007/s13139-018-0563-4
    91 sgo:license sg:explorer/license/
    92 sgo:sdDataset articles
    93 rdf:type schema:ScholarlyArticle
    94 N23e47edddf8d40f188c5da9d5055f22a schema:name pubmed_id
    95 schema:value 30828398
    96 rdf:type schema:PropertyValue
    97 N3a4f64e4514a4a5881170e3d2ba03e57 schema:name doi
    98 schema:value 10.1007/s13139-018-0563-4
    99 rdf:type schema:PropertyValue
    100 N625ce9e6d0214a7b884c9e36bbaa46a1 schema:name Springer Nature - SN SciGraph project
    101 rdf:type schema:Organization
    102 N8ba641a7573941f6973ac5ac3195024d schema:name dimensions_id
    103 schema:value pub.1110668571
    104 rdf:type schema:PropertyValue
    105 Nc8926295acf741d3a95aff19daed2f94 rdf:first sg:person.0620177742.17
    106 rdf:rest rdf:nil
    107 Ndbe85781c8ea48a38461512676e9217a schema:volumeNumber 53
    108 rdf:type schema:PublicationVolume
    109 Nf12f1409d9a04984a95874361d246a55 schema:issueNumber 1
    110 rdf:type schema:PublicationIssue
    111 anzsrc-for:02 schema:inDefinedTermSet anzsrc-for:
    112 schema:name Physical Sciences
    113 rdf:type schema:DefinedTerm
    114 anzsrc-for:0299 schema:inDefinedTermSet anzsrc-for:
    115 schema:name Other Physical Sciences
    116 rdf:type schema:DefinedTerm
    117 sg:grant.5904522 http://pending.schema.org/fundedItem sg:pub.10.1007/s13139-018-0563-4
    118 rdf:type schema:MonetaryGrant
    119 sg:journal.1016285 schema:issn 1869-3474
    120 1869-3482
    121 schema:name Nuclear Medicine and Molecular Imaging
    122 schema:publisher Springer Nature
    123 rdf:type schema:Periodical
    124 sg:person.0620177742.17 schema:affiliation grid-institutes:grid.412002.5
    125 schema:familyName Kinuya
    126 schema:givenName Seigo
    127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620177742.17
    128 rdf:type schema:Person
    129 sg:pub.10.1007/s00259-017-3919-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100478294
    130 https://doi.org/10.1007/s00259-017-3919-6
    131 rdf:type schema:CreativeWork
    132 sg:pub.10.1007/s12149-012-0590-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038929936
    133 https://doi.org/10.1007/s12149-012-0590-7
    134 rdf:type schema:CreativeWork
    135 sg:pub.10.1007/s12149-015-0960-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1006620729
    136 https://doi.org/10.1007/s12149-015-0960-z
    137 rdf:type schema:CreativeWork
    138 sg:pub.10.1007/s12149-017-1163-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084034239
    139 https://doi.org/10.1007/s12149-017-1163-6
    140 rdf:type schema:CreativeWork
    141 sg:pub.10.1007/s12149-017-1201-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091287901
    142 https://doi.org/10.1007/s12149-017-1201-4
    143 rdf:type schema:CreativeWork
    144 sg:pub.10.1007/s12149-017-1207-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1091594397
    145 https://doi.org/10.1007/s12149-017-1207-y
    146 rdf:type schema:CreativeWork
    147 sg:pub.10.1007/s12149-017-1216-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1092351426
    148 https://doi.org/10.1007/s12149-017-1216-x
    149 rdf:type schema:CreativeWork
    150 sg:pub.10.1007/s12149-018-1230-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100399578
    151 https://doi.org/10.1007/s12149-018-1230-7
    152 rdf:type schema:CreativeWork
    153 sg:pub.10.1007/s12149-018-1233-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100471058
    154 https://doi.org/10.1007/s12149-018-1233-4
    155 rdf:type schema:CreativeWork
    156 sg:pub.10.1007/s12149-018-1242-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101142948
    157 https://doi.org/10.1007/s12149-018-1242-3
    158 rdf:type schema:CreativeWork
    159 sg:pub.10.1007/s12149-018-1264-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1104152081
    160 https://doi.org/10.1007/s12149-018-1264-x
    161 rdf:type schema:CreativeWork
    162 sg:pub.10.1007/s12149-018-1275-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105345400
    163 https://doi.org/10.1007/s12149-018-1275-7
    164 rdf:type schema:CreativeWork
    165 sg:pub.10.1007/s12149-018-1276-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105856637
    166 https://doi.org/10.1007/s12149-018-1276-6
    167 rdf:type schema:CreativeWork
    168 sg:pub.10.1007/s12149-018-1277-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105568984
    169 https://doi.org/10.1007/s12149-018-1277-5
    170 rdf:type schema:CreativeWork
    171 sg:pub.10.1007/s12149-018-1290-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106125946
    172 https://doi.org/10.1007/s12149-018-1290-8
    173 rdf:type schema:CreativeWork
    174 sg:pub.10.1007/s12149-018-1291-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106150181
    175 https://doi.org/10.1007/s12149-018-1291-7
    176 rdf:type schema:CreativeWork
    177 sg:pub.10.1007/s12149-018-1304-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107121645
    178 https://doi.org/10.1007/s12149-018-1304-6
    179 rdf:type schema:CreativeWork
    180 sg:pub.10.1007/s12149-018-1312-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109759418
    181 https://doi.org/10.1007/s12149-018-1312-6
    182 rdf:type schema:CreativeWork
    183 sg:pub.10.1007/s12149-018-1317-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110227037
    184 https://doi.org/10.1007/s12149-018-1317-1
    185 rdf:type schema:CreativeWork
    186 grid-institutes:grid.412002.5 schema:alternateName Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takaramachi, 920-8641, Kanazawa, Ishikawa, Japan
    187 schema:name Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takaramachi, 920-8641, Kanazawa, Ishikawa, Japan
    188 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...